BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37392366)

  • 1. A new model (Alfalfa-Warfarin-GIB) for predicting the risk of major gastrointestinal bleeding in warfarin patients.
    Wu S; Lv M; Ma F; Feilong Z; Fang G; Zhang J
    Eur J Clin Pharmacol; 2023 Sep; 79(9):1195-1204. PubMed ID: 37392366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new model to predict the risk of major gastrointestinal bleeding in patients on direct oral anticoagulants (dabigatran and rivaroxaban).
    Lv M; Jiang S; Wu T; Huang N; Chen X; Chen C; Zhang J
    Br J Clin Pharmacol; 2023 Jan; 89(1):253-260. PubMed ID: 35971682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Effectiveness of Machine Learning Approaches for Predicting Gastrointestinal Bleeds in Patients Receiving Antithrombotic Treatment.
    Herrin J; Abraham NS; Yao X; Noseworthy PA; Inselman J; Shah ND; Ngufor C
    JAMA Netw Open; 2021 May; 4(5):e2110703. PubMed ID: 34019087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction).
    Aisenberg J; Chatterjee-Murphy P; Friedman Flack K; Weitz JI; Ruff CT; Nordio F; Mercuri MF; Choi Y; Antman EM; Braunwald E; Giugliano RP
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003998. PubMed ID: 29748353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal hemorrhage in warfarin anticoagulated patients: incidence, risk factor, management, and outcome.
    Chen WC; Chen YH; Hsu PI; Tsay FW; Chan HH; Cheng JS; Lai KH
    Biomed Res Int; 2014; 2014():463767. PubMed ID: 24987683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
    Garcia DA; Fisher DA; Mulder H; Wruck L; De Caterina R; Halvorsen S; Granger CB; Held C; Wallentin L; Alexander JH; Lopes RD
    Am Heart J; 2020 Mar; 221():1-8. PubMed ID: 31896036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation.
    Qureshi W; Mittal C; Patsias I; Garikapati K; Kuchipudi A; Cheema G; Elbatta M; Alirhayim Z; Khalid F
    Am J Cardiol; 2014 Feb; 113(4):662-8. PubMed ID: 24355310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The outcome and role of drugs in patients with unexplained gastrointestinal bleeding.
    Hreinsson JP; Bjarnason I; Bjornsson ES
    Scand J Gastroenterol; 2015; 50(12):1482-9. PubMed ID: 26087014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding.
    Witt DM; Delate T; Garcia DA; Clark NP; Hylek EM; Ageno W; Dentali F; Crowther MA
    Arch Intern Med; 2012 Oct; 172(19):1484-91. PubMed ID: 22987143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk score to predict gastrointestinal bleeding after acute ischemic stroke.
    Ji R; Shen H; Pan Y; Wang P; Liu G; Wang Y; Li H; Singhal AB; Wang Y;
    BMC Gastroenterol; 2014 Jul; 14():130. PubMed ID: 25059927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the US Food and Drug Administration Sentinel Analysis Tools Using a Comparator with a Different Indication: Comparing the Rates of Gastrointestinal Bleeding in Warfarin and Statin Users.
    Carnahan RM; Gagne JJ; Hampp C; Leonard CE; Toh S; Fuller CC; Hennessy S; Hou L; Cocoros NM; Panucci G; Woodworth T; Cosgrove A; Iyer A; Chrischilles EA
    Pharmaceut Med; 2019 Feb; 33(1):29-43. PubMed ID: 31933271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warfarin Is Associated With Higher Rates of Upper But Not Lower Gastrointestinal Bleeding Compared with Direct Oral Anticoagulants: A Population-Based Propensity-Weighted Cohort Study.
    Ingason AB; Hreinsson JP; Agustsson AS; Lund SH; Rumba E; Palsson DA; Reynisson IE; Gudmundsdottir BR; Onundarson PT; Bjornsson ES
    Clin Gastroenterol Hepatol; 2023 Feb; 21(2):347-357.e10. PubMed ID: 35977616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study.
    Sengupta N; Feuerstein JD; Patwardhan VR; Tapper EB; Ketwaroo GA; Thaker AM; Leffler DA
    Am J Gastroenterol; 2015 Feb; 110(2):328-35. PubMed ID: 25512338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restarting Warfarin vs Direct Oral Anticoagulants After Major Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A Cohort Study.
    Tapaskar N; Ham SA; Micic D; Sengupta N
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):381-389.e9. PubMed ID: 33227428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project.
    Esteve-Pastor MA; Rivera-Caravaca JM; Roldan V; Vicente V; Valdés M; Marín F; Lip GYH
    Thromb Haemost; 2017 Oct; 117(10):1848-1858. PubMed ID: 28799620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.
    Apostolakis S; Lane DA; Guo Y; Buller H; Lip GY
    J Am Coll Cardiol; 2012 Aug; 60(9):861-7. PubMed ID: 22858389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton Pump Inhibitor Utilization in Veteran Patients on Combined Antithrombotic Therapy and Validation of Simplified Bleeding Risk Score.
    Patil T; Murphy K; Woodard L; Lebrecht M
    Pharmacotherapy; 2020 Dec; 40(12):1219-1227. PubMed ID: 33073362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin.
    Senoo K; Proietti M; Lane DA; Lip GY
    Am J Med; 2016 Jun; 129(6):600-7. PubMed ID: 26482233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of restarting warfarin therapy in renal disease anticoagulated patients with gastrointestinal hemorrhage.
    Khalid F; Qureshi W; Qureshi S; Alirhayim Z; Garikapati K; Patsias I
    Ren Fail; 2013 Oct; 35(9):1228-35. PubMed ID: 23902367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New score for predicting major bleeding in patients with atrial fibrillation using direct oral anticoagulants.
    Chen J; Lv M; Xu W; Zhang F; Huang N; Chen X; Zhang W; Hu W; Su J; Dai H; Gu P; Huang X; Du X; Li R; Zheng Q; Lin X; Zhang Y; Liu Y; Zhang M; Liu X; Zhu Z; Sun J; Zhang J
    Int J Cardiol; 2023 Apr; 376():56-61. PubMed ID: 36791968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.